Oxford University researchers have captured the step-by-step assembly of individual virus-like particles, revealing how simple molecular interactions can…
EpilepsyGTx, a biotechnology company developing gene therapies for refractory epilepsy, and Viralgen, a leading contract development and manufacturing…
From blocking inflammatory immune pathways to disrupting hepatitis viruses, scorpion-derived peptides are attracting attention as potential drug candidates,…